Skip to main content

Diagnosis of low-grade periprosthetic infections

Ref-Nr: TA-ESA-FMEMD113


Kurzfassung

The diagnosis of low-grade periprosthetic infections is difficult and time consuming. The invention provides a novel approach to differentiate highly specific between septic and aseptic tissue using a tissue biopsy.


Hintergrund

The number of arthroplasties is growing and a proportional increase of infections comes with it. There are early periprosthetic joint infections which are associated with symptoms such as pain, loss of function, fever and other indicators for inflammation etc. and which are detectable by several parameters e.g. white blood cell count or C-reactive protein level. Low-grade infections, however, are more difficult to detect as they do not always evoke the described symptoms and in most cases are only identified at very late stages. Recently proposed markers for bacterial infection do not distinguish with high specificity and sensitivity between septic and aseptic tissue. The late diagnosis of infection often leads to severe complications and an explantation of the infected prosthesis becomes unavoidable instead of applying appropriate treatment if it would have been diagnosed earlier.


Problemstellung

Therefore, new markers are needed for early diagnosis of low-grade infections.


Lösung

The present study revealed that components of the terminal complement pathway may be suitable biomarkers for this purpose. The proposed marker differentiates between septic and aseptic tissue with a predictive specificity of 100 % and a sensitivity of 88.89 %.


Vorteile

  • Early detection of periprosthetic infections
  • Highly specific differentiation between septic and aseptic tissue
  • Distress for patients can be reduced
  • Cost for treatment at early stages would be lower
  • Explantation can possibly be avoided
  • Time before necessary exchange of implants may be prolonged

Anwendungsbereiche

  • Diagnosis of infections related to arthroplasties
  • Human medicine

Service

ESA PVA is – in the name of the Medical Faculty of the Otto-von-Guericke-University Magdeburg - seeking partners who would be interested in developing a diagnostic for patients. Scientific assistance for an industrial partner can be assured in a proper way within the frame of further the development for the market and market entry.


ESA Patentverwertungsagentur Sachsen-Anhalt GmbH

Dr. Sigrun Hähnel
+49 (0) 391 8107220
info@esa-pva.de
www.esa-pva.de
Adresse
Breitscheidstraße 51
39114 Magdeburg



Entwicklungsstand

Funktionsnachweis


Patentsituation

  • EP anhängig

Stichworte

periprosthetic infections, septic and aseptic tissue, tissue biopsy, arthroplasties, biomarker

Angebot Anbieter-Website


Kontakt | Geschäftsstelle

TechnologieAllianz e. V.
Christiane Bach-Kaienburg
(Geschäftsstellenleiterin)

c/o PROvendis GmbH
Schloßstr. 11-15
D-45468 Mülheim an der Ruhr